Filing Flows

Filing Flows › Companies › Enovix › Cash flow

Enovix cash flow, quarter by quarter

Latest: Q2 2026 · from the cash-flow statements filed with the SEC

Free cash flow−$31.4M in Q2 2026 · −$124M over twelve months

Operating cash flow−$21.8M
Capital spending−$9.6M
Free cash flow−$31.4M
Cash conversion cycle76 days

Analysis

In Q2 2026, Enovix generated −$21.8M of operating cash flow and spent $9.6M on capital projects, leaving free cash flow of −$31.4M.

Over the twelve months to Jul 5, 2026, operating cash flow was −$107M; the largest uses were other investing ($456M), operating cash flow ($107M), capital spending ($16.8M); besides operations, cash came from net borrowing (+) / repaid (−) ($361M), other financing ($112M); the cash balance fell by $102M.

Operating cash flow was −$21.8M against net income of −$43.1M. The largest differences: stock-based pay +$13.0M, depreciation & amortization +$10.0M, accrued liabilities +$2.4M.

Its cash conversion cycle was 76 days (receivables 35 + inventory 200 − payables 160).

Free cash flow

Enovix: free cash flow by quarterEnovix: free cash flow by quarter−$50.2MQ3 2024−$32.3MQ4 2024−$23.2MQ1 2025−$33.8MQ2 2025−$28.5MQ3 2025−$28.0MQ4 2025−$36.3MQ1 2026−$31.4MQ2 2026
Operating cash flow less capital spending.
Enovix: operating cash flow against capital spendingEnovix: operating cash flow against capital spendingOperating cash flowCapital spending−$30.7M$19.5MQ3 2024−$16.0M$16.4MQ4 2024−$16.9M$6.3MQ1 2025−$25.9M$8.0MQ2 2025−$25.5M$3.0MQ3 2025−$27.0M$1.0MQ4 2025−$33.1M$3.2MQ1 2026−$21.8M$9.6MQ2 2026
Latest (Q2 2026): Operating cash flow −$21.8M, Capital spending $9.6M.

Capital allocation, year by year

Enovix: where the cash came from (up) and went (down), by fiscal yearEnovix: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedCapital spendingAcquisitionsBuybacksFY2022: Operating cash flow −$51.3MFY2022: Net borrowing −$15.0MFY2022: Shares issued $190KFY2022: Capital spending −$43.6MFY2022: Buybacks −$27K$190KFY2022FY2023: Operating cash flow −$82.7MFY2023: Shares issued $2.4MFY2023: Capital spending −$36.2MFY2023: Buybacks −$10K$2.4MFY2023FY2023: Operating cash flow −$105MFY2023: Net borrowing $172MFY2023: Shares issued $11.9MFY2023: Capital spending −$61.8MFY2023: Acquisitions −$10.0M$184MFY2023FY2024: Operating cash flow −$109MFY2024: Net borrowing −$418KFY2024: Shares issued $152MFY2024: Capital spending −$76.2M$152MFY2024FY2025: Operating cash flow −$95.3MFY2025: Net borrowing $359MFY2025: Shares issued $3.3MFY2025: Capital spending −$18.2MFY2025: Buybacks −$58.4M$362MFY2025
Over these 5 years operating cash flow totalled −$443M; the largest uses were operating cash flow ($443M) and capital spending ($236M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$476M
Debt$532M
Net debt$55.8M
Due within a year$230K
Cash runway3.8 years

Enovix is burning cash: its operations consume cash, a free cash flow of −$124M a year at the current rate against $476M of cash and investments: a runway of about 3.8 years; $230K of debt also comes due within a year, which the cash covers before any new financing.

Enovix: debt maturities by year (FY2025)Enovix: debt maturities by year (FY2025)$230KYear 1$172KYear 2$173MYear 3$360MYear 5
Principal due in each year as disclosed in the annual report, against $476M of cash and investments now.

Where the cash came from and went

Enovix: sources (+) and uses (−) of cash, Q2 2026Enovix: sources (+) and uses (−) of cash, Q2 2026Cash drawn (+) / kept (−)$55.0MOther investing−$24.0MOperating cash flow−$21.8MCapital spending−$9.6MOther financing$466KExchange rates−$55K
Enovix: sources (+) and uses (−) of cash, TTM to Q2 2026Enovix: sources (+) and uses (−) of cash, TTM to Q2 2026Other investing−$456MNet borrowing (+) / repaid (−)$361MOther financing$112MOperating cash flow−$107MCash drawn (+) / kept (−)$102MCapital spending−$16.8MAcquisitions$10.0MTaxes on employees’ shares−$7.1MShares issued$2.6MExchange rates−$636K

From profit to cash

Enovix: net income to operating cash flow, Q2 2026Enovix: net income to operating cash flow, Q2 2026Net income−$43.1MDepreciation & amortization$10.0MStock-based pay$13.0MOther non-cash−$1.1MReceivables$766KInventory−$1.4MPayables−$77KAccrued liabilities$2.4MDeferred revenue−$592KPrepaid and other assets−$117KOther liabilities−$928KOperating cash flow−$21.8M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q2 20263520016076
Q1 20265424426532
Q3 2025511982435
Q2 202544197284-44
Q1 202567171283-46
Q4 20243090129-8
Q3 202438175316-104

Every quarter

QuarterOperating cash flowCapital spendingAcquisitionsBuybacksNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q2 2026−$21.8M−$9.6M————$55.0M−$31.4M
Q1 2026−$33.1M−$3.2M——−$55K—$17.3M−$36.3M
Q4 2025−$27.0M−$1.0M$10.0M—−$125K$209K$230M−$28.0M
Q3 2025−$25.5M−$3.0M—−$58.4M$360M$2.4M−$199M−$28.5M
Q2 2025−$25.9M−$8.0M−$10.0M—−$813K—$53.6M−$33.8M
Q1 2025−$16.9M−$6.3M−$16K——$782K$83.0M−$23.2M
Q4 2024−$16.0M−$16.4M——−$29K$67.7M−$71.7M−$32.3M
Q3 2024−$30.7M−$19.5M—$1K−$107K$1.5M$34.0M−$50.2M

Enovix: income statement and cash flow

Enovix, Q2 2026: revenue $9.0M (+21% year over year), operating margin -479.8%. The chart follows the revenue to costs, profit and cash.

Enovix: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.